ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

HSCSW Heart Test Laboratories Inc

0,0381
-0,002 (-4,99%)
Dernière mise à jour : 19:19:49
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Heart Test Laboratories Inc HSCSW NASDAQ Warrant
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,002 -4,99% 0,0381 19:19:49
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,0381 0,0381 0,0381 0,0401
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
20/5/202415:00GLOBEHeartSciences Announces Further Internationalization of its..
16/5/202418:30EDGAR2Form 8-K/A - Current report: [Amend]
15/5/202414:00EDGAR2Form 8-K - Current report
24/4/202415:00GLOBEHeartSciences Announces Grant of Fundamental Patent by the..
02/4/202422:15GLOBEHeartSciences to Present at the LD Micro Invitational XIV..
26/3/202414:00GLOBEHeartSciences Announces Podium Presentation at World..
14/3/202421:15GLOBEHeartSciences Reports Third Quarter Fiscal 2024 Financial..
12/3/202414:00GLOBEHeartSciences’ Announces Peer-Reviewed Publication..
06/3/202415:00GLOBEHeartSciences Announces Canada Patent Grant Covering..
26/2/202415:00GLOBEHeartSciences Adds Key Advisor to its Scientific Advisory..
12/2/202415:00GLOBEHeartSciences Expands its Scientific Advisory Board
01/2/202415:00GLOBEHeartSciences Appoints New Scientific Advisory Board Member
18/1/202414:00GLOBEHeartSciences Announces Results and Adjournment of Annual..
03/1/202422:15GLOBEHeartSciences Reminds Stockholders to Vote at the Upcoming..
14/12/202322:15GLOBEHeartSciences Reports Second Quarter Fiscal 2024 Financial..
05/12/202314:00GLOBEHeartSciences Receives FDA Confirmation for 510(k) Clearance..
20/11/202314:00GLOBEHeartSciences Announces Closing of License Agreements with..
13/11/202314:45GLOBEHeartSciences’ MyoVista® wavECGTM Selected for Heart..
19/10/202315:00GLOBEHeartSciences Issues Investor Update Highlighting Recent Key..
26/9/202314:00GLOBEHeartSciences Receives Two New Patent Allowances, Expanding..
25/9/202314:00GLOBEHeartSciences to Participate in the Maxim Group Virtual Tech..
21/9/202314:00GLOBEHeartSciences Signs Definitive Agreements with the Icahn..
14/9/202322:15GLOBEHeartSciences Reports First Quarter Fiscal 2024 Financial..
12/9/202322:15GLOBEHeartSciences to Present at the Gilmartin Group Emerging..
11/9/202322:15GLOBEHeartSciences Named Electrocardiography Advancement..
07/9/202315:00GLOBEHeartSciences Signs Distribution Agreement with MedPhy..
31/8/202315:00GLOBEHeartSciences Signs Distribution Agreement with FJ Medical,..
24/8/202315:00GLOBEHeartSciences’ MyoVista® wavECGTM Selected to be used in..
17/8/202315:00GLOBEHeartSciences Announces Further Expansion of Artificial..
27/7/202315:00GLOBEMyoVista wavECG goes into clinical use at the Naya Imaging..
19/7/202315:00GLOBEHeartSciences Provides Business Update and Reports Fiscal..

Dernières Valeurs Consultées

Delayed Upgrade Clock